Click here to close now.




















Welcome!

News Feed Item

Global Genes Partners With SWAN USA To Help Undiagnosed Rare Disease Patients Seek A Medical Diagnosis Through Free Whole Exome Sequencing Program

Parabase Genomics and the UCLA Clinical Genomics Center Selected as Pilot Partners

ALISO VIEJO, Calif., Feb. 04, 2014 /PRNewswire-USNewswire/ -- Eight years. That's the average amount of time patients wait to receive an official medical diagnosis when facing a rare genetic disease. The stress this medical diagnostic process places on families can be devastating. This year, undiagnosed rare disease patients will receive a gift of hope through an innovative whole genome sequencing pilot program developed and funded by Global Genes in partnership with SWAN USA (Syndromes Without A Name).

The collaborative agreement between Global Genes and SWAN USA will allow undiagnosed rare disease patients who cannot afford costly genomic testing – which can range from $3,500 to more than $5,000 per test - to obtain free clinical genomic sequencing testing to aid in finding the genetic source of their mysterious illnesses.  Boston-based Parabase Genomics and the UCLA Clinical Genomics Center have been selected as the first clinical genomic sequencing providers for the pilot project. 

Starting March 1, 2014, approximately 30 undiagnosed patients will undergo free whole exome sequencing, funded by Global Genes through a donor directed fund launched last September at the 2nd Annual Tribute to Champions of Hope event. With additional funding underway, the program is expected to expand and include more undiagnosed patients.

"We are thrilled to be working with leading genomic sequencing providers on both coasts to help patients in our community find  diagnoses for their rare and genetic diseases," said Andrea Epstein, Executive Director, Global Genes. "We talk to patients, parent advocates and families every day who have had the misfortune of receiving up to three misdiagnoses and are facing diseases that have eluded medical professionals for years due to lack of access to the most cutting edge testing techniques."

Global Genes established a multi-disciplinary committee and a formal Request for Proposal process to select Parabase Genomics and UCLA's Clinical Genomics Center as the initial genomic sequencing partners for the pilot project. This committee reflected a diverse group of rare and genetic disease stakeholders including parent advocates, patient foundation leaders, clinical advisors and Global Genes executives.  The team included Amy Clugston, Founder of SWAN USA, Caroline Loewy, EVP and CFO Tobira Therapeutics and parent advocate, Cristy Spooner, parent advocate, Gary Jackson PhD, Genetics and Technology Consultant, Heather Long, Founder of U.R. Our Hope, Nicole Boice, President, Global Genes and Andrea Epstein, Executive Director, Global Genes.

Global Genes' partner on the project, SWAN USA, is equally enthusiastic about the potential effect on families that this genetic testing will bring.

"Families face an incredible emotional and economic hardship as they struggle to find a proper diagnosis for their loved ones disease," said Amy Clugston, Founder and President, SWAN USA. "To be a part of this innovative program and have the capacity to aid families locate the resources they need is exactly our goal."

Helping to make this technology a reality for undiagnosed patients is Boston-based Parabase Genomics and the UCLA Clinical Genomics Center based in Los Angeles.

"It's our pleasure to join this circle of passionate advocates and experts by providing a timely diagnosis to these deserving patients and their families," said Andy Bhattachariee, PhD, CEO and Scientific Director of Parabase.  "In 2014, we look forward to helping these families, and others, with our LifeTime RareDx Test.  One of the challenges with translation of next-generation sequencing to newborns and children is the long time it takes to get results.  We have developed a complete workflow from blood to a medical report in 2-4 weeks, and our plan is to shorten this timeline to a few days."

The UCLA Clinical Genomics Center also shared their enthusiasm as the West Coast sequencing provider in this new collaborative program. "We are honored and pleased to partner with Global Genes and SWAN USA to accelerate the diagnosis of those affected by rare and genetic diseases," added Dr. Stan Nelson, Professor, Department of Human Genetics, UCLA.

About Global Genes

Global Genes is a leading rare and genetic disease patient advocacy organization.  The organization mission is to 'Eliminate the Challenges of Rare Disease', by equipping patients to become successful advocates, and through education and empowerment, become 'activists' for their disease.  Global Genes does this through a growing portfolio of educational tools and resources, events, building out critical connections and funding innovations in science and technology that will impact patients within their lifetime.  Recognized worldwide by the Blue Denim Genes Ribbon™, Global Genes unites experts, advocates and patients of all ages to stand together in hope for treatments and cures for the estimated 7,000 rare and genetic diseases that impact approximately 30 million Americans and over 250 million people worldwide. For more information about Global Genes™, please visit the following links:

About SWAN USA

SWAN USA is a non-profit tax exempt organization that offers support, information and advice to families of children living with an undiagnosed condition – or a syndrome without a name. The organization offers support, advice and information on the challenges that families face when there is no diagnosis and advocates for changes in the medical community that will benefit undiagnosed individuals.  To learn more about SWAN USA, visit www.undiagnosed-usa.org.

About Parabase Genomics

Parabase Genomics is a privately held molecular diagnostics company focused on changing the way newborns and children with genetic disorders are diagnosed and treated. The Company's LifeTime Tests™ are the first commercially available services that provide a rapid non-invasive method for sample collection and diagnosis of genetic conditions using dried blood spots. This proprietary genetic and informational platform generates actionable information about a newborn's disease profile. Physicians can now avoid delays and adverse consequences by running one single test that is equivalent to several hundred parallel diagnostic tests commonly used today. To learn more, visit http://www.parabasegenomics.com.

About the UCLA Clinical Genomics Center

With expertise in Pediatrics, Human Genetics, and Pathology, the UCLA Clinical Genomics Center provides a comprehensive analysis and diagnostic interpretation of a patient's entire protein-encoding genome by searching through 37 million base pairs in 20,000 genes to potentially locate the single DNA change responsible for the patient's disorder. The Center, part of the David Geffen School of Medicine at UCLA, utilizes next generation sequencing technology, state-of-the-art computational and bioinformatic resources, and integrated laboratory information systems to deliver a precise genetic diagnosis for the benefit of patients and physicians. To learn more, visit: http://pathology.ucla.edu.

SOURCE Global Genes

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Consumer IoT applications provide data about the user that just doesn’t exist in traditional PC or mobile web applications. This rich data, or “context,” enables the highly personalized consumer experiences that characterize many consumer IoT apps. This same data is also providing brands with unprecedented insight into how their connected products are being used, while, at the same time, powering highly targeted engagement and marketing opportunities. In his session at @ThingsExpo, Nathan Trel...
Red Hat is investing in Tesora, the number one contributor to OpenStack Trove Database as a Service (DBaaS) also ranked among the top 20 companies contributing to OpenStack overall. Tesora, the company bringing OpenStack Trove Database as a Service (DBaaS) to the enterprise, has announced that Red Hat and others have invested in the company as a part of Tesora's latest funding round. The funding agreement expands on the ongoing collaboration between Tesora and Red Hat, which dates back to Febr...
IBM’s Blue Box Cloud, powered by OpenStack, is now available in any of IBM’s globally integrated cloud data centers running SoftLayer infrastructure. Less than 90 days after its acquisition of Blue Box, IBM has integrated its Blue Box Cloud Dedicated private-cloud-as-a-service into its broader portfolio of OpenStack® based solutions. The announcement, made today at the OpenStack Silicon Valley event, further highlights IBM’s continued support to deliver OpenStack solutions across all cloud depl...
Everyone talks about continuous integration and continuous delivery but those are just two ends of the pipeline. In the middle of DevOps is continuous testing (CT), and many organizations are struggling to implement continuous testing effectively. After all, without continuous testing there is no delivery. And Lab-As-A-Service (LaaS) enhances the CT with dynamic on-demand self-serve test topologies. CT together with LAAS make a powerful combination that perfectly serves complex software developm...
Through WebRTC, audio and video communications are being embedded more easily than ever into applications, helping carriers, enterprises and independent software vendors deliver greater functionality to their end users. With today’s business world increasingly focused on outcomes, users’ growing calls for ease of use, and businesses craving smarter, tighter integration, what’s the next step in delivering a richer, more immersive experience? That richer, more fully integrated experience comes ab...
With the proliferation of connected devices underpinning new Internet of Things systems, Brandon Schulz, Director of Luxoft IoT – Retail, will be looking at the transformation of the retail customer experience in brick and mortar stores in his session at @ThingsExpo. Questions he will address include: Will beacons drop to the wayside like QR codes, or be a proximity-based profit driver? How will the customer experience change in stores of all types when everything can be instrumented and a...
Culture is the most important ingredient of DevOps. The challenge for most organizations is defining and communicating a vision of beneficial DevOps culture for their organizations, and then facilitating the changes needed to achieve that. Often this comes down to an ability to provide true leadership. As a CIO, are your direct reports IT managers or are they IT leaders? The hard truth is that many IT managers have risen through the ranks based on their technical skills, not their leadership ab...
WSM International, the pioneer and leader in server migration services, has announced an agreement with WHOA.com, a leader in providing secure public, private and hybrid cloud computing services. Under terms of the agreement, WSM will provide migration services to WHOA.com customers to relocate some or all of their applications, digital assets, and other computing workloads to WHOA.com enterprise-class, secure cloud infrastructure. The migration services include detailed evaluation and planning...
In today's digital world, change is the one constant. Disruptive innovations like cloud, mobility, social media, and the Internet of Things have reshaped the market and set new standards in customer expectations. To remain competitive, businesses must tap the potential of emerging technologies and markets through the rapid release of new products and services. However, the rigid and siloed structures of traditional IT platforms and processes are slowing them down – resulting in lengthy delivery ...
The Internet of Things (IoT) is about the digitization of physical assets including sensors, devices, machines, gateways, and the network. It creates possibilities for significant value creation and new revenue generating business models via data democratization and ubiquitous analytics across IoT networks. The explosion of data in all forms in IoT requires a more robust and broader lens in order to enable smarter timely actions and better outcomes. Business operations become the key driver of I...
Puppet Labs has announced the next major update to its flagship product: Puppet Enterprise 2015.2. This release includes new features providing DevOps teams with clarity, simplicity and additional management capabilities, including an all-new user interface, an interactive graph for visualizing infrastructure code, a new unified agent and broader infrastructure support.
A producer of the first smartphones and tablets, presenter Lee M. Williams will talk about how he is now applying his experience in mobile technology to the design and development of the next generation of Environmental and Sustainability Services at ETwater. In his session at @ThingsExpo, Lee Williams, COO of ETwater, will talk about how he is now applying his experience in mobile technology to the design and development of the next generation of Environmental and Sustainability Services at ET...
U.S. companies are desperately trying to recruit and hire skilled software engineers and developers, but there is simply not enough quality talent to go around. Tiempo Development is a nearshore software development company. Our headquarters are in AZ, but we are a pioneer and leader in outsourcing to Mexico, based on our three software development centers there. We have a proven process and we are experts at providing our customers with powerful solutions. We transform ideas into reality.
Skeuomorphism usually means retaining existing design cues in something new that doesn’t actually need them. However, the concept of skeuomorphism can be thought of as relating more broadly to applying existing patterns to new technologies that, in fact, cry out for new approaches. In his session at DevOps Summit, Gordon Haff, Senior Cloud Strategy Marketing and Evangelism Manager at Red Hat, discussed why containers should be paired with new architectural practices such as microservices rathe...
In their Live Hack” presentation at 17th Cloud Expo, Stephen Coty and Paul Fletcher, Chief Security Evangelists at Alert Logic, will provide the audience with a chance to see a live demonstration of the common tools cyber attackers use to attack cloud and traditional IT systems. This “Live Hack” uses open source attack tools that are free and available for download by anybody. Attendees will learn where to find and how to operate these tools for the purpose of testing their own IT infrastructu...